Product image of Brineura (Cerliponase Alfa) supplied by GNH India

Brineura

Active Ingredient:
Cerliponase Alfa
Origin:
EU

Brineura (Cerliponase Alfa)

Brineura (Cerliponase Alfa) is an enzyme replacement therapy used for intracerebroventricular administration. It is designed to address specific genetic conditions, offering targeted treatment options for eligible patients.

Manufacturer / TM Owner

Biomarin International Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Brineura is primarily used for the treatment of a rare genetic disorder affecting the central nervous system. This medication is administered directly into the brain to help manage symptoms associated with this condition. Patients and healthcare providers often explore 'what is Brineura used for' to understand its role in managing this specific disorder.

Side Effects

  • Brineura may help in reducing the progression of neurological symptoms in patients with the targeted genetic condition. Common effects include improvements in motor function and cognitive abilities, though individual responses can vary. Patients should discuss potential outcomes with their healthcare provider.

Precautions & Warnings

  • Brineura should be administered under strict medical supervision due to its complex delivery method. Patients should be monitored for any adverse reactions, and the medication should be stored and handled according to the manufacturer's guidelines to ensure safety and efficacy.

Avoid Interactions

  • Brineura may interact with other medications, particularly those that affect the central nervous system. Patients should inform their healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions.

Frequently Asked Questions

Brineura is used to treat a rare genetic disorder affecting the central nervous system, helping to manage symptoms and slow disease progression.

Brineura is administered directly into the brain through intracerebroventricular infusion, a procedure performed by healthcare professionals.

Common effects include improvements in motor function and cognitive abilities, though individual responses can vary.

Yes, Brineura should be administered under strict medical supervision, and patients should be monitored for any adverse reactions.

Yes, Brineura may interact with other medications, particularly those affecting the central nervous system.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cerliponase Alfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT